In 2024, the International Diabetes Federation (IDF) reported that 589 million people worldwide live with diabetes [1], a condition encompassing a spectrum of metabolic disorders characterized by hyperglycemia resulting from either impaired insulin secretion, defective insulin action, or a combination of both mechanisms [2]. This evidence concerns the gene INS and metabolic disease.